38 reports

Neuromodulation treatment involves direct stimulation or modulation of the nerves by an electrical or magnetic field. It is used as a treatment for unmanageable chronic pain, movement disorders, gastroenterology, urology and others. The treatment delivered by neuromodulation devices brings about life-changing transformation...

  • Neuromodulation Device
  • World
  • United States
  • Medical Technology Density

## NEUROSTIMULATION AND NEUROMODULATION DEVICES

  • Neuromodulation Device
  • Europe
  • North America
  • United States
  • Japan
  • APAC
  • Health Expenditure
  • Drug Approval

Neuromodulation Device -

  • Neuromodulation Device
  • World
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Prescription Drug Sales
  • Direct Sales

Neuromodulation Devices

  • Neuromodulation Device
  • Brazil
  • BRIC
  • China
  • Russia
  • India
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • APAC
  • Australia
  • China
  • Japan
  • South Korea
  • India
  • Direct Sales
  • Hospital Revenue

Neuromodulation Devices

  • Neuromodulation Device
  • Mexico
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • India
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Italy
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Spain
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Russia
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Brazil
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Canada
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Australia
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • China
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Germany
  • Direct Sales
  • Oral Surgeries

Devices

  • Neuromodulation Device
  • North America
  • Mexico
  • Canada
  • Drug Approval
  • Direct Sales

Neuromodulation Devices

  • Neuromodulation Device
  • France
  • Direct Sales
  • Prescription Drug Sales

Neuromodulation Devices

  • Neuromodulation Device
  • Japan
  • Direct Sales
  • Fuel Price

Neuromodulation Devices

  • Neuromodulation Device
  • South Korea
  • Direct Sales
  • Outpatient Facility Number

Neuromodulation Devices

  • Neuromodulation Device
  • Private Placement
  • United Kingdom
  • Prescription Drug Sales
  • Direct Sales

Neuromodulation Devices

  • Neuromodulation Device
  • World
  • United States
  • Drug Approval
  • Direct Sales

Global Neuromodulation Market: About this market This neuromodulation market analysis considers sales from implantable neuromodulation devices and external neuromodulation devices. Our study also finds the sales of neuromodulation in Asia, Europe, North America, and ROW. In 2019, the implantable neuromodulation devices...

  • Neuromodulation Device
  • World
  • Chronic Disease Prevalence

United States Neurology Devices Market Outlook to 2025 - Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others. Summary new report, United States Neurology Devices Market Outlook to 2025, provides key market data on the United States Neurology Devices...

  • Neurology
  • Neuromodulation Device
  • Neurological Disorder
  • United States
  • World

Neuromodulation Devices (Neurology) - Global Market Analysis and Forecast Model Summary Neuromodulation Devices (Neurology) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Neurology Devices therapeutic area. Neuromodulation devices are...

  • Neuromodulation Device
  • World

United States Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others Summary GlobalData’s new report, United States Neurology Devices Market Outlook to 2025, provides key market data on the United States Neurology...

  • Neuromodulation Device
  • Neurological Disorder
  • Neurology
  • Surgery
  • In-Store Retail
  • Diagnostics
  • United States
  • World

Major players in the neurostimulation devices market are Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, and Nevro Corporation. The global neurostimulation devices market is expected to grow from $5.77 billion in 2020 to $6.59 billion in 2021 at a compound annual growth rate (CAGR) of 14.2%. The growth is mainly...

  • Medical Device
  • Chronic Pain
  • Cardiac Management
  • Neuromodulation Device
  • Psychotic Disorder
  • Neurological Disorder
  • World

This study covers the world outlook for neuromodulation devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Neuromodulation Device
  • World
  • Gross Domestic Product
  • Disposable Income

This study covers the world outlook for internal neuromodulations devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These...

  • Neuromodulation Device
  • World
  • Gross Domestic Product
  • Disposable Income

North America Neuromodulation Device Musculoskeletal Disorder Analgesic Infectious Disease

  • Neuromodulation Device
  • Analgesic
  • Musculoskeletal Disorder
  • North America
  • Drug Approval
  • Medical Devices Sales

APAC Neuromodulation Device Musculoskeletal Disorder Analgesic Infectious Disease

  • Analgesic
  • Neuromodulation Device
  • Musculoskeletal Disorder
  • APAC
  • Drug Approval
  • Disposable Income